# Study Investigating the Effect of Idalopirdine on Cardiac Repolarisation in Healthy Men

> **NCT02436486** · PHASE1 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 76 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Placebo
- **DRUG:** ldalopirdine 120 mg
- **DRUG:** Idalopirdine 360 mg
- **DRUG:** Moxifloxacin 400 mg

## Key facts

- **NCT ID:** NCT02436486
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2015-08
- **Final completion:** —
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2015-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02436486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02436486, "Study Investigating the Effect of Idalopirdine on Cardiac Repolarisation in Healthy Men". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02436486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*